Last year, China approved 76 innovative drugs, setting a new record.
According to the National Medical Products Administration, 76 innovative drugs were approved for market release in China in 2025, significantly exceeding the 48 approved in all of 2024 and setting a new record high. In addition, the total value of licensing transactions for innovative drugs in China exceeded $130 billion in 2025, with the number of transactions surpassing 150—also a record high. (CCTV News)
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
GRAM (Gram, prev. Toncoin) price pulls back to $1.057, hitting a nearly 365-day low
-
2
BCH (Bitcoin Cash) trading volume reached $2.1 million over the past hour (15.2x its average for the same period over the past 7 days), currently trading at $247.900.
-
3
2026 US Stock Market Safe-Haven Assets Encyclopedia: How Walmart and Caterpillar Lead the Industrial Sector Amid AI Bubble Doubts
-
4
Real-World Use Cases and Impact of Blockchain Brawlers (BRWL)
-
5
What Cryptocurrency Is ADR? A Deep Dive into the Solana Meme Project American Dollar Reserve
-
6
Current Status of BUSD (Binance USD): Issuance Halted, Orderly Wind-Down Underway
-
7
How is BFHT doing? What is the future outlook for BFHT?
-
8
Challenges and Issues Facing Ethereum Even After the Completion of the Ethereum 2.0 Upgrade
-
9
USDT Perpetual Contract Auto-Margin Deposition: Mechanism, Trigger Conditions, and Risks
-
10
What is the METIS Token? An Analysis of Metis' Technical Architecture and Transition Progress
Markets Today
Recommended Reading







